Picture of Aspire-lakewood Holdings logo

ASBP — Aspire-lakewood Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+2.75%
3m+33.08%
6m-1.97%
1yr-98.21%
Volume Change (%)
10d/3m-81.74%
Price vs... (%)
52w High-98.47%
50d MA+3.72%
200d MA-63.91%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-52.34%
Return on Equity-1032.14%
Operating Margin-6353.18%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Aspire-lakewood Holdings EPS forecast chart

Profile Summary

Aspire-Lakewoood Holdings, Inc., formerly Aspire Biopharma Holdings, Inc., through its subsidiary, Dura Control Systems Corp. (DCSC), is a designer and manufacturer of highly engineered automotive and industrial control systems that combine mechanical engineering, electronics and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain agnostic product portfolio that includes mechatronic actuators, human machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates 11 manufacturing facilities globally and serves as a tier one automotive supplier to major OEMs and other industrial firms. The Company also engages in the business of developing and marketing disruptive technology for novel sublingual delivery mechanisms initially for known drugs and supplements, such as aspirin and caffeine products.

Directors

    Last Annual
    December 31st, 2025
    Last Interim
    June 30th, 2026
    Incorporated
    February 17th, 2025
    Public Since
    February 18th, 2022
    No. of Shareholders
    396
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    1,402,557

    ASBP Share Price Performance

    Upcoming Events for ASBP

    Similar to ASBP

    Picture of 60 Degrees Pharmaceuticals logo

    60 Degrees Pharmaceuticals

    us flag iconNASDAQ Capital Market

    Picture of Abeona Therapeutics logo

    Abeona Therapeutics

    us flag iconNASDAQ Capital Market

    Picture of Akari Therapeutics logo

    Akari Therapeutics

    us flag iconNASDAQ Capital Market

    Picture of Akebia Therapeutics logo

    Akebia Therapeutics

    us flag iconNASDAQ Capital Market

    Picture of Alpha Cognition logo

    Alpha Cognition

    us flag iconNASDAQ Capital Market

    FAQ